腎疾患政策研究事業
（○：委員長）
| ○ | 小山 哲夫 | 筑波大学名誉教授 | |
| 腎臓学 | |||
| Glomerulonephritis associated with MRSA infection: A possible role of bacterial Int 1995; 47:207-216 (Koyama A, Kobayashi M, Yamaguchi N et al. | |||
| A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity.(Koyama A, Yamagata K, Makino H et al. Clin Exp Nephrol. 2009 Dec; 13(6):633-50 | |||
| Risk factors for chronic kidney disease in a community-based population: a 10-year follow up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Koyama A. 2007 Jan: 71; (2): 159-66 | |||
| 相川 厚 | 東邦大学・名誉教授 | ||
| 腎移植、腎臓学、泌尿器科学 | |||
| （研究論文その１） Trends in ABO-incompatible kidney transplantation. Aikawa A, Saito K, Takahashi K.Exp Clin Transplant. 2015;13 Suppl 1:18-22. |
|||
| （研究論文その２） Mineral disorders in pediatric pre-emptive kidney transplantation.Hasegawa K, Motoyama O, Shishido S, Aikawa A. Pediatr Int. 2019;61(6):587-594. |
|||
| （研究論文その３） Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.Sugiyama K, Hyodo Y, Aikawa A.Int J Urol. 2015;22(10):931-936. |
|||
| 富野康日己 | 医療法人社団松和会 理事長 順天堂大学 名誉教授 |
||
| 腎臓内科学 | |||
| The Influence of an Unexpected Switch of Hemodialysis Facilities on the Quality of Life (QOL) in Hemodialysis Patients. Yoshio Shimizu, Keiichi Wakabayashi, Junichiro Nakata, Hiroaki Io, Chieko Hamada, Yasuhiko Tomino, Yusuke Suzuki. International Journal of Nephrology and Renovascular Disease. 2022 April 13; 15:151-160. DOI: 10.2147/UNRD.S358915. eCollection 2022 | |||
| Post-Operative Kidney Function Using Deep Hypothermic Circulatory Arrest (DHCA) in Aortic Arch Operation. Masahide Higo, Yoshio Shimizu, Keiichi Wakabayashi, Takehiko Nakano, Yasuhiko Tomino, Yusuke Suzuki. International Journal of Nephrology and Renovascular Disease 2022: 15 239-252, Sep 26. DOI: 10.2147/IJNRD.S373828 |
|||
| 「ドクター富野のもっともわかりやすいCKD集中講義」富野康日己(著)、総合医学社 2022年1月15日 | |||
| 下條 文武 | 新潟薬科大学・学長 | ||
| 内科・腎臓内科 | |||
| Macromolecular crowding and supersaturation protect hemodialysis patients from the onset of dialysis-related amyloidosis. Nakajima K, Yamaguchi K, Noji M, Aguirre C, Ikenaka K, Mochizuki H, Zhou L, Ogi H, Ito T, Narita I, Gejyo F, Naiki H, Yamamoto S, Goto Y. Nature Communications. 2022 Oct 3. doi:10.1038/s41467-022-33247-3 |
|||
| Efficacy and safety of difelikefalin in Japanese patients with moderate to severe pruritus receiving hemodialysis: A randomized clinical trial. Narita I, Tsubakihara Y, Uchiyama T, Okamura S, Oya N, Takahashi N, Gejyo F; MR13A9-4 Trial Investigators. JAMA Network Open. 2022 May 2;5(5):e2210339. doi:10.1001 |
|||
| Adsorption of protein-bound uremic toxins using activated carbon through direct hemoperfusion in vitro. Yamamoto S, Ito T, Sato M, Goto S, Kazama JJ, Gejyo F, Narita I. Blood Purification. 2019;48(3):215-222. doi:10.1159/000500014. |
|||
| 西﨑 祐史 | 順天堂大学 医学部医学教育研究室 | ||
| 一般内科、医学教育 | |||
| Nishizaki Y, Miyauchi K, Iwata H, Inoue T, Hirayama A, Kimura K, Ozaki Y, Murohara T, Ueshima K, Kuwabara Y, Tanaka-Mizuno S, Yanagisawa N, Sato T, Daida H. Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study. Am Heart J. 2023 Mar; 257: 1-8. |
|||
| Nishizaki Y, Kuroki H, Ishii S, Ohtsu S, Watanabe C, Nishizawa H, Nagao M, Nojima M, Watanabe R, Sato D, Sato K, Kawata Y, Wada H, Toyoda G, Ohbayashi K. Determining Optimal Intervals for In-Person Visits During Video-Based Telemedicine Among Patients With Hypertension: Cluster Randomized Controlled Trial. JMIR Cardio. 2023 Jun 8; 7: e45230. |
|||
| Nishizaki Y, Nagasaki K, Shikino K, Kurihara M, Shinozaki T, Kataoka K, Shimizu T, Yamamoto Y, Fukui S, Nishiguchi S, Katayama K, Kobayashi H, Tokuda Y. Relationship between COVID-19 care and burnout among postgraduate clinical residents in Japan: a nationwide cross-sectional study. BMJ Open. 2023 Jan 13; 13(1): e066348. |
|||
